http://purl.org/np/RAH1Zfq1jqDONwDWim8KXAYK0aEMaVfiDp2mfKJlRXCJQ
.trig | .trig.txt | .jelly | .jelly.txt
@prefix dcterms: <http://purl.org/dc/terms/> . @prefix ns1: <http://www.w3.org/ns/prov#> . @prefix this: <http://purl.org/np/RAH1Zfq1jqDONwDWim8KXAYK0aEMaVfiDp2mfKJlRXCJQ> . @prefix sub: <http://purl.org/np/RAH1Zfq1jqDONwDWim8KXAYK0aEMaVfiDp2mfKJlRXCJQ#> . @prefix schema: <https://schema.org/> . @prefix np: <http://www.nanopub.org/nschema#> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix nt: <https://w3id.org/np/o/ntemplate/> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix orcid: <https://orcid.org/> . @prefix bl: <https://w3id.org/biolink/vocab/> . @prefix npx: <http://purl.org/nanopub/x/> . sub:Head { this: a np:Nanopublication; np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo . } sub:assertion { <http://purl.obolibrary.org/obo/DOID_9352> bl:category bl:Disease . sub:association a rdf:Statement; rdf:object <http://purl.obolibrary.org/obo/DOID_9352>; rdf:predicate bl:treats; rdf:subject <https://identifiers.org/drugbank:DB09043>; rdfs:label "tanzeum is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies 14 limitations of use see warnings and precautions 5 1 see warnings and precautions 5 2 see adverse reactions 6 1 tanzeum is a glp 1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus 1 limitations of use 1 5 1 1 5 2 1 1 1"; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:provided_by <https://w3id.org/um/NeuroDKG>; bl:relation schema:TreatmentIndication . <https://identifiers.org/drugbank:DB09043> bl:category bl:Drug . } sub:provenance { sub:assertion ns1:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "ROLH7L7kFFqAj3EkwBcKyQm0+2Suw8zl0o/HxdZaPTCh/J9Pm7ci9jTN2QjuzaaDw8lRoSP7Ii00Xvt8QGowJzw45bKo+UqJU3+ICfFNzIh+g9sPbYFcy1lL9o0GyKm02GzVPLbOtcAiZfaYUWRjqQ1BeV91FURN7LDn1AQ2LT8="; npx:hasSignatureTarget this: . this: dcterms:created "2021-07-03T14:48:16.285+02:00"^^xsd:dateTime; dcterms:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>; nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>; nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> . }